The role of patent analysis in target selection
Daniel H. O’Donovan(AstraZeneca (United Kingdom)), Gerjan de Bruin(N. V. Pharma (India)), Weiping Wang(Zhejiang Sci-Tech University), Jim Sheppeck(AstraZeneca (Brazil))
Cited by 2
Related Papers
Constructing robust heterostructured interface for anode-free zinc batteries with ultrahigh capacities
|Nature Communications|2023|317
Treatment of oily waste water by PVP grafted PVDF ultrafiltration membranes
|Chemical Engineering Journal|2015|171
Genome maps across 26 human populations reveal population-specific patterns of structural variation
|Nature Communications|2019|171
An Ultrafast and Ultra-Low-Temperature Hydrogen Gas–Proton Battery
|Journal of the American Chemical Society|2021|164
High throughput screening technologies for ion channels
|Acta Pharmacologica Sinica|2015|143